Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy-Reference-Cited by-同舟云学术

Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy

Published:2014-01 Issue:1 Volume:16 Page:122-134
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Wang Yingying,Aïssi-Rothe Lamia,Virion Jean Marc,De Carvalho Bittencourt Marcelo,Ulas Neslihan,Audonnet Sandra,Salmon Alexandra,Clement Laurence,Venard Veronique,Jeulin Helène,Stoltz Jean-François,Decot Veronique,Bensoussan Danièle

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference38 articles.

1. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection;Rickinson;Annu Rev Immunol,1997

2. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection;Mautner;Eur J Cell Biol,2012

3. The immune response to Epstein-Barr virus;Callan;Microbes Infect,2004

4. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation;Landgren;Blood,2009

5. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases;Styczynski;Transpl Infect Dis,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell-mediated immunity during Epstein–Barr virus infections in children;Infection, Genetics and Evolution;2023-08

2. Protective Role ofγδT Cells in Different Pathogen Infections and Its Potential Clinical Application;Journal of Immunology Research;2018-07-10

3. EBV transformation induces overexpression of hMSH2/3/6 on B lymphocytes and enhances γδT-cell-mediated cytotoxicity via TCR and NKG2D;Immunology;2018-04-16

4. Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study;Cytotherapy;2018-04

5. Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial;Journal of Hematology & Oncology;2017-05-08